ctrl K

Price Alert

ADC Therapeutics S.A. (ADCT)

NYSE: ADCT · Real-Time Price · USD

3.13

-0.06 (-1.88%)

At close: Aug 15, 2025, 3:59 PM

3.13

-0.04%

After-hours: Aug 15, 2025, 06:42 PM EDT

ADC Therapeutics S.A. Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	250.87M	278.6M	326.44M	466.54M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.65M	7.61M	41.24M
Other Long-Term Assets	1.16M	711K	903K	693K
Receivables	20.32M	25.18M	72.97M	30.22M
Inventory	18.39M	16.18M	12.07M	11.12M
Other Current Assets	9.45M	5.99M	199K	1.95M
Total Current Assets	307.39M	336.29M	434.98M	525.18M
Property-Plant & Equipment	13.43M	16.13M	10.26M	11.23M
Goodwill & Intangibles	n/a	n/a	14.36M	13.58M
Total Long-Term Assets	14.59M	18.49M	55.88M	92.79M
Total Assets	321.98M	354.78M	490.86M	617.97M
Account Payables	18.03M	15.57M	12.35M	12.08M
Deferred Revenue	n/a	n/a	n/a	3.75M
Short-Term Debt	n/a	n/a	12.47M	6.58M
Other Current Liabilities	47.47M	37.94M	16.56M	8.97M
Total Current Liabilities	80.47M	67.67M	81.94M	73.94M
Long-Term Debt	113.63M	112.73M	109.71M	125.1M
Other Long-Term Liabilities	322.53M	312.45M	838K	3.65M
Total Long-Term Liabilities	444.15M	435.36M	329.47M	377.95M
Total Liabilities	524.62M	503.03M	411.41M	451.88M
Total Debt	123M	124.38M	117.38M	101.75M
Common Stock	8.43M	7.31M	7.31M	6.45M
Retained Earnings	-1.49B	-1.34B	-1.1B	-924.88M
Comprehensive Income	-1.42M	-93K	1.82M	102.83M
Shareholders Equity	-202.64M	-148.25M	79.45M	166.09M
Total Investments	n/a	1.65M	7.61M	41.24M